KumbyAI is the AI-powered analyst that synthesizes news, identifies risks, and delivers actionable intelligence for quality and compliance professionals.
A real-time look at the news KumbyAI is analyzing right now.
Fierce Biotech
less than a minute ago
Zoll Medical, the maker of devices and software focused on cardiopulmonary and respiratory conditions, was slammed in an FDA warning letter that outlined numerous quality control and medical device reporting violations.
Fierce Biotech
less than a minute ago
As Moderna reshapes itself in the wake of the pandemic, the company on Thursday passed a key milestone in its bid to expand the reach of its mRNA platform to the massive influenza vaccination market.
Fierce Biotech
less than a minute ago
In another biotech born out of China’s “NewCo” model, cAMPfield Therapeutics has launched with a $180 million series A and a focus on oral medicines for inflammatory diseases.
Fierce Biotech
less than a minute ago
Novocure’s tumor-treating electric fields device missed its primary endpoint in a late-stage glioblastoma trial.
Fierce Biotech
less than a minute ago
Innoviva has revealed the next steps for Langer Lab assets it rescued from Lyndra Therapeutics’ collapse, launching Nortiva Bio to develop long-acting oral medicines and pursue drug development alliances.
Fierce Biotech
less than a minute ago
Kardigan’s IPO haul has come in 14% above expectations, grossing $400 million after the cardiovascular disease biotech upsized the offering and hit the top end of its target range.